CGM
LLY icon

Capital Growth Management’s Eli Lilly LLY Stock Holding History

Capital Growth Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-70,000
Closed -$11.5M – 57
2020
Q2 		$11.5M Buy
70,000
+60,000
+600% +$9.21M 1.34% 32
2020
Q1 		$1.39M Buy
+10,000
New +$1.37M 0.19% 42
2019
Q1 		– Sell
-50,000
Closed -$5.79M – 62
2018
Q4 		$5.79M Sell
50,000
-355,000
-88% -$39.7M 0.36% 37
2018
Q3 		$43.5M Buy
+405,000
New +$40.5M 2.25% 16

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Growth Management's LLY Position: Q3 2020 in Review

Capital Growth Management sold out of Eli Lilly (LLY) in Q3 2020, closing a stake of 70,000 shares — an estimated $11.5M sold.

Capital Growth Management first reported a position in LLY in Q3 2018 and held it in 4 quarters. The position peaked at $43.5M in Q3 2018. 1,773 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • Capital Growth Management reported no remaining Eli Lilly position as of Q3 2020 after selling out during the quarter.
  • Capital Growth Management sold 70,000 Eli Lilly shares in Q3 2020, an estimated $11.5M.
  • Capital Growth Management first reported a position in Eli Lilly in Q3 2018 and held it in 4 quarters.
  • Capital Growth Management's Eli Lilly position peaked at $43.5M in Q3 2018.
  • 1,773 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on Capital Growth Management's 13F filing for Q3 2020, filed 12 Nov 2020.